TGF-beta/Smad
TGF-beta/Smad inhibitors are compounds that interfere with the TGF-beta (Transforming Growth Factor-beta) signaling pathway, which is mediated by Smad proteins. This pathway is involved in the regulation of cell growth, differentiation, apoptosis, and stem cell function. Dysregulation of TGF-beta/Smad signaling is associated with cancer, fibrosis, and other diseases. Inhibitors of this pathway are important tools for studying these conditions and developing potential therapies. At CymitQuimica, we provide TGF-beta/Smad inhibitors to support your research in cell signaling, oncology, and tissue repair.
Read more
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (+)-ITD-1 REF: TM-T201672CAS: 1409968-46-2 | - - - | To inquire | Tue 15 Jul 25 |
| TGFβ1-IN-1 REF: TM-T61389CAS: 2348795-14-0 | 99.89% | 90.00 € | Tue 15 Jul 25 |
| TGFβRI-IN-3 REF: TM-T9523CAS: 2763602-67-9 | 98.02% | 88.00 €~2,593.00 € | Tue 29 Jul 25 |
(+)-ITD-1
CAS:1409968-46-2
(+)-ITD-1 is an inhibitor of TGF-β, effectively inhibiting TGF-β2 with an IC50 of 0.46 μM. …
Formula:
C27H29NO3
Color and Shape:
Liquid
Molecular weight:
415.52
Ref: TM-T201672
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 15 Jul 2025
TGFβ1-IN-1
CAS:2348795-14-0
TGFβ1-IN-1 is a TGF-β1 inhibitor that inhibits the production of TGF-β1-induced fibrosis markers (α-SMA and …
Formula:
C22H24N2O3
Purity:
99.89%
Color and Shape:
Liquid
Molecular weight:
364.438
Ref: TM-T61389
| 2mg | 90.00 € |
Estimated delivery in United States, on Tuesday 15 Jul 2025
TGFβRI-IN-3
CAS:2763602-67-9
TGFβRI-IN-3 inhibits TGFβR1 with an IC 50 of 0.79 nM with 2000-fold selectivity against MAP4K4.
Formula:
C28H23N3O2S
Purity:
98.02%
Color and Shape:
Soild
Molecular weight:
465.57
Ref: TM-T9523
| 1mg | 88.00 € | ||
| 5mg | 187.00 € | ||
| 10mg | 298.00 € | ||
| 25mg | 582.00 € | ||
| 50mg | 908.00 € | ||
| 100mg | 1,301.00 € | ||
| 500mg | 2,593.00 € | ||
| 1mL*10mM (DMSO) | 187.00 € |
Estimated delivery in United States, on Tuesday 29 Jul 2025
